Guardian Laboratories Profile
Key Indicators
- Authorised Capital ₹ 6.00 M
as on 09-12-2024
- Paid Up Capital ₹ 2.27 M
as on 09-12-2024
- Company Age 22 Year, 9 Months
- Last Filing with ROC 31 Mar 2019
- Open Charges ₹ 1.06 Cr
as on 09-12-2024
- Satisfied Charges ₹ 2.78 Cr
as on 09-12-2024
- Revenue %
(FY 2017)
- Profit -263.68%
(FY 2017)
- Ebitda -480.72%
(FY 2017)
- Net Worth 22.91%
(FY 2017)
- Total Assets -31.37%
(FY 2017)
About Guardian Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 6.00 M and a paid-up capital of Rs 2.27 M.
The company currently has active open charges totaling ₹1.06 Cr. The company has closed loans amounting to ₹2.78 Cr, as per Ministry of Corporate Affairs (MCA) records.
Soma Datta, Rajat Roy, and Kartik Datta serve as directors at the Company.
- CIN/LLPIN
U24231WB2002PTC094292
- Company No.
094292
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Feb 2002
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
24 Parganas, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Guardian Laboratories?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Soma Datta  | Director | 04-Jun-2014 | Current |
| Rajat Roy | Director | 04-Jun-2014 | Current |
| Kartik Datta | Director | 28-Jul-2014 | Current |
Financial Performance and Corporate Structure Insights of Guardian Laboratories.
Guardian Laboratories Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 263.68% decrease in profit. The company's net worth Soared by an impressive increase of 22.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Guardian Laboratories?
In 2017, Guardian Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Central Bank Of India Creation Date: 02 Apr 2005 | ₹2.60 M | Open |
West Bengal Financial Corporation Creation Date: 18 Jun 2003 | ₹8.00 M | Open |
Allahabad Bank Creation Date: 27 Jun 2007 | ₹1.72 Cr | Satisfied |
How Many Employees Work at Guardian Laboratories?
Unlock and access historical data on people associated with Guardian Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Guardian Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Guardian Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
